RxDoctor Payments Data

Joseph Aferzon, MD

Surgery · Portland, CTNPI 1316960594

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $596,661 of the $711,615 with a category attached, or 83.8%. Alphatec Spine, Inc accounts for 92.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $170,272 and has fallen 65.1% since, to $59,438 in 2025. Among surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$711,615in general payments, 2019–2025

Across 126 payments — averaging $5647.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$659K
  • Spinefrontier, Inc.$51K
  • Corelink, LLC$567
  • Medtronic$205
  • Abbott$205
  • Boston Scientific$90
  • plus $147 from 4 others

What the payments were for

  • Royalty or licence$596,66184%
  • Consulting fees$89,57713%
  • Travel & lodging$20,8033%
  • Food & beverage$4,5751%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$711,615 in reported general payments places this provider in the 95th percentile of 289 surgery providers in Connecticut.

See all surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$32,685
Medicare patients
35
Services billed
85

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin23$240
Tramadol Hcl16$61

Paid to pharmacies, not to this prescriber.

Other surgery in Portland

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →